Goldman Sachs Group »

Mirati Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.4M 75k 58.75
2023-09-30 $1.5M 35k 43.56
2023-06-30 $1.5M 41k 36.13
2023-03-31 $1.8M 48k 37.18
2022-12-31 $13M 293k 45.31
2022-06-30 $164M 2.4M 67.13
2022-03-31 $11M 129k 82.22
2021-12-31 $34M 233k 146.69
2021-09-30 $35M 196k 176.91
2021-03-31 $71M 413k 171.30
2020-12-31 $110M 499k 219.64
2020-09-30 $93M 562k 166.05
2020-06-30 $44M 381k 114.17
2019-12-31 $49M 379k 128.86
2019-09-30 $27M 352k 77.91
2019-06-30 $30M 286k 103.00
2019-03-31 $22M 306k 73.30
2018-12-31 $3.3M 78k 42.41
2018-09-30 $4.6M 97k 47.11
2018-06-30 $2.3M 47k 49.29
2018-03-31 $5.2M 170k 30.70
2017-12-31 $591k 32k 18.24
2017-06-30 $359k 98k 3.65
2017-03-31 $54k 10k 5.20
2016-09-30 $450k 68k 6.61
2016-06-30 $203k 37k 5.46
2014-12-31 $506k 27k 18.54
2014-03-31 $542k 28k 19.05
2013-12-31 $446k 27k 16.61
2013-09-30 $517k 34k 15.14